Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01726673 · ClinicalTrials.gov registry record · Phase 2
Robots Paired With tDCS in Stroke Recovery
A Phase 2 study, sponsored by Northwell Health.
- Completed
- Registry status
- Phase 2
- Development phase
- 54
- Enrollment target
NCT01726673 is a Phase 2 study that has completed, run by Northwell Health. The registered enrollment target is 54 participants.
The verdict
NCT01726673, a Phase 2 study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 54 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate if multiple therapy sessions of Transcranial Direct Current Stimulation (tDCS non-invasive brain stimulation) combined with robotic arm therapy lead to a greater functional recovery in upper limb mobility after stroke than that provided by robotic arm therapy alone.
Interventions
- DEVICE Transcranial Direct Current Stimulation (tDCS)
- DEVICE Placebo sham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2012-09 |
| Est. Completion | 2018-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01726673
The ClinicalTrials.gov registry entry for NCT01726673 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Transcranial Direct Current Stimulation (tDCS) is the first listed.
NCT01726673 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01726673 about?
NCT01726673 is a clinical study titled "Robots Paired With tDCS in Stroke Recovery". The purpose of this study is to evaluate if multiple therapy sessions of Transcranial Direct Current Stimulation (tDCS non-invasive brain stimulation) combined with robotic arm therapy lead to a greater functional recovery in upper limb mobility after stroke than that provided by robotic arm therapy...
What is the current status of trial NCT01726673?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 54 participants. The study started on 2012-09. Estimated completion is 2018-06.
What interventions are being tested in trial NCT01726673?
The interventions under investigation include: Transcranial Direct Current Stimulation (tDCS) (DEVICE), Placebo sham (DEVICE).
Who is sponsoring clinical trial NCT01726673?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.